Walleye Capital
AMPH icon

Walleye Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Walleye Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,666
Closed -$322K – 4211
2024
Q4 		$322K Buy
+8,666
New +$396K ﹤0.01% 3361
2024
Q3 		– Sell
-5,017
Closed -$201K – 5226
2024
Q2 		$201K Buy
+5,017
New +$208K ﹤0.01% 4301
2023
Q4 		– Sell
-39,854
Closed -$1.83M – 4926
2023
Q3 		$1.83M Buy
+39,854
New +$2.17M 0.03% 1806
2023
Q2 		– Sell
-23,231
Closed -$871K – 4297
2023
Q1 		$871K Buy
+23,231
New +$762K 0.02% 1271
2022
Q1 		– Sell
-30,267
Closed -$705K – 2266
2021
Q4 		$705K Buy
+30,267
New +$619K 0.02% 778

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return